Kimberly Stegmaier, MD, Professor of Pediatrics at Harvard Medical School and the Ted Williams Chair at Dana-Farber Cancer Institute, has advanced the application of genomics to drug and protein target discovery for leukemia. She is the Vice-Chair for Pediatric Oncology Research, Co-director of the Pediatric Hematologic Malignancy Program, a pediatric oncologist at the Dana-Farber Cancer Institute and Boston Children’s Hospital, and an Institute Member of the Broad Institute. She’s the recipient of the Joanne Levy, MD, Memorial Award for Outstanding Achievement from the American Society of Hematology, a SU2C Innovative Research Grant, the E. Mead Johnson Award for Research in Pediatrics, and an NCI Outstanding Investigator Award. She was elected to the American Society of Clinical Investigation and the Association of American Physicians. She received her undergraduate degree from Duke University where she graduated valedictorian, medical degree from Harvard Medical School, and trained in Pediatric Hematology/Oncology at Boston Children’s Hospital and Dana-Farber Cancer Institute.